GOVERNANCE

Executive Committee

Executive Committee members

David Seignolle

Chief Executive Officer
Learn more

David Seignolle

Chief Executive Officer

Appointed: December 2024
Nationality: French

David Seignolle is the Chief Executive Officer of EUROAPI. He was previously Chief Operating Officer of the Company. He joined EUROAPI from Bain & Company where he served as Expert Partner in the Healthcare Practice.

Prior to this, David spent 6 years at TEVA where he held several positions such as Head of Operations for Teva API in Italy and Mexico, Vice President Global Supply Chain API and Biologics or Site General Manager. David has also served 5 years at McKinsey & Company in France and in the US where he was focusing on Pharma Operations after beginning his career in Procurement at Toyota Motor Europe. 

David has a degree in Mechanical Engineering & Industrial Science as well as a postmaster degree in International Procurement Management.

In his personal time, David enjoys spending time with his wife and 2 young children and is a passionate golfer.

Olivier Falut

Chief Financial Officer
Learn more

Olivier Falut

Chief Financial Officer

Appointed: October 2024
Nationality: French

Olivier Falut is the Chief Financial Officer at EUROAPI. He started his career in the financial audit sector, mainly at Ernst & Young in France and then in the United States. In 2001, he joined Bosch France as head of accounting and pursued his career as accounting director at Bel in 2003. 

In 2008, he joined Oberthur Technologies as CFO for the main business unit before moving to Lactalis (2012-2017) as head of group financial control. Since 2017, he has held CFO positions in various companies including Sodiaal, Segula Technologies, Limagrain and Fareva. 
  
Olivier Falut is a graduate from ESSEC business school and holds master’s degrees in business law. He also graduated from the French bar exam. 

Sylvia Cabrillac-Rives

Chief Strategy Officer
Learn more

Sylvia Cabrillac-Rives

Chief Strategy Officer

Appointment: December 2024
Nationality: French


Sylvia Cabrillac-Rives is the Chief Strategy Officer at EUROAPI. She is in charge of a department combining strategy, public affairs, ESG and strategic programs. 

She began her career at Hoechst Marion Roussel in clinical trials, before moving to a marketing position at Aventis.  She then moved to Sanofi, where she held a number of management positions, including Director of Public Affairs Ile-de-France, Director of Operations Centre Aquitaine and Director Overseas.  From 2017, she was a member of the Management Committee of Sanofi's French subsidiary as Director of Transversal Commercial Operations. 

After this highly diversified career in the pharmaceutical industry, she joined EUROAPI at the end of 2020 as Head of Public Affairs.
Sylvia holds a Master's degree in Biochemistry, Biophysics and Molecular Biology from Toulouse's Paul Sabatier University, as well as a DESS and DU in Industrial Pharmacy from Montpellier's Faculty of Pharmacy.

Outside her professional career, she likes to recharge her batteries in the countryside, hiking in the mountains or playing golf. She also enjoys cooking and spending time with her family. 
 

Thierry Durand

Chief Research & Development Officer
Learn more

Thierry Durand

Chief Research & Development Officer

Appointed: October 2022
Nationality: French

Thierry Durand is Chief Research & Development Officer of EUROAPI managing Process and Analytical development activities, pilot scale manufacturing, development projects and external collaborations.
He began his career in 1993 in France in Small Molecules API Process Research at Synthélabo before joining Rhône-Poulenc for different roles in Process Development and Project Management for seven years. After three years as Senior Project Manager for Merial for the development of new APIs, Thierry joined Novasep in 2005 as R&D and Project Management Director for the small molecules business unit for ten years, before moving to Strategic Project Management leading new services for antibody-drug conjugates and viral vector capex management.
In 2019, Thierry has been the Managing Director of Minakem, before moving in 2021 to Corden as VP Project Management and project management officer.
For the past year, he has been consulting for private equity funds and consulting offices on pharma BtoB M&A topics.
Thierry holds a master’s degree in chemical sciences from Ecole Supérieure de Chimie Industrielle de Lyon (ESCIL) with a double degree in Organic Chemistry from Université Claude Bernard in Lyon and a PhD in Organic Chemistry from Université Catholique de Louvain-La-Neuve. 
Thierry is passionate about ski and fragrance creation.

Elizabeth Ehringer

Chief People Officer
Learn more

Elizabeth Ehringer

Chief People Officer

Appointed: June 2024
Nationality: French

Elizabeth Ehringer is the Chief People Officer at EUROAPI. Elizabeth joins EUROAPI from Hager Group, a company specializing in energy management solutions and services, where she was Human Resources Operations Vice President and part of the Global Leader Management Team. Previously, she held human resources positions at NTN SNR, BigMat, CRH and BIC (until 2009). 

Elizabeth Ehringer joined Waters Corporation in 2006 as HR Director Europe & India, having previously worked in the healthcare sector as a human resources director for Galderma and Abbott Pharmaceutical (formerly Fournier). She started her career in HR for various international companies such as Schlumberger Systems and Nacco Materials Handling Group. 

A graduate of IAE Nancy in HR executive management and labor law and of the Universities of Sheffield and Germersheim, Elizabeth Ehringer has international experience in Europe and North America. She also holds a Board Director Certificate from the Institut Français des Administrateurs (IFA) and is a Chevalier of the Legion of Honor.

In her free time, Elizabeth enjoys cooking and discovering wines. She is passionate about literature and classical music.

Guillaume Rosso

Chief Commercial Officer
Learn more

Guillaume Rosso

Chief Commercial Officer

Appointed: April 2024
Nationality: French

Guillaume joined the Sanofi Group in 2017, working on key M&A projects before being appointed IPO M&A Manager in 2020. In this role, he led the Pluton project, heading up the preparation and execution of the EUROAPI IPO process.

Guillaume brings over 13 years of experience in the pharmaceutical industry to this position. His career began at PwC, where he was first an auditor and later the Transaction Services Manager.

He is a graduate of EM LYON business school, where he holds a degree in Finance – Management.

In his free time, Guillaume loves to travel and experience other cultures.